21032-48-4 Purity
>95.0%(GC)
If you have any other questions or need other size, please get a quote.
Reference: [1]Current Patent Assignee: ABBVIE INC - US2004/167123, 2004, A1
Location in patent: Page/Page column 70
[2]Le Count, D. J.; Dewsbury, D. J.
[Synthesis, 1982, # 11, p. 972 - 973]
[3]Usifoh, Cyril; Igbinaduwa, Patrick
[Acta poloniae pharmaceutica, 2007, vol. 64, # 3, p. 281 - 284]
[4]Current Patent Assignee: GLAXOSMITHKLINE PLC - WO2003/87088, 2003, A2
Location in patent: Page/Page column 37
Reference: [1] Patent: US5441955, 1995, A,
Reference: [1]Journal of Heterocyclic Chemistry,1985,vol. 22,p. 193 - 206
Reference: [1]Coppola, Gary M.; Fraser, James D.; Hardtmann, Goetz E.; Shapiro, Michael J.
[Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 193 - 206]
* For details of the synthesis route, please refer to the original source to ensure accuracy.